Showing results (1031-1040 of 2,791) with videos related to

Sort By:
Pageof 280
Drugs & Aging|August 31, 2007
Bleeding during enoxaparin treatment more common with age over 75 years and severe renal insufficiencyNebojsa Despotovic, Predrag Erceg, Maja Nikolic-Despotovic, et al.
Drugs & Aging|October 28, 2006
Management of Parkinson's disease dementia : practical considerationsArvid Rongve, Dag Aarsland
Drugs & Aging|July 21, 2004
Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactionsPeter H Canter, Edzard Ernst
Drugs & Aging|August 25, 2004
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's diseaseDirk Deleu, Yolande Hanssens, Margaret G Northway
Drugs & Aging|August 25, 2004
The impact of fragility fracture on health-related quality of life : the importance of antifracture therapyTed Xenodemetropoulos, Shawn Davison, George Ioannidis, et al.
Drugs & Aging|August 25, 2004
Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysisJoseph Menzin, Kathleen Lang, Craig C Earle, et al.
Drugs & Aging|August 3, 2005
Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's diseaseDong-Churl Suh, Simu K Thomas, Elmira Valiyeva, et al.
Drugs & Aging|May 1, 1992
Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive declineA N Wadworth, P Chrisp
Drugs & Aging|October 17, 2003
Complementary and alternative medicines in the treatment of dementia: an evidence-based reviewBruce Diamond, Susan Johnson, Kathleen Torsney, et al.
Drugs & Aging|July 11, 1992
The use of oral fluoroquinolones in nursing home patientsT M File, J S Tan
Pageof 280